|
|||||
|
|
Probiotics: A possible specific liver drug for non-alcoholic fatty liver disease |
|
| Authors: | Ming-Hua Zheng Yong-Ning Xin Xiao-Niao Cai Li-Xin Qiu |
| Institution: | a Department of Infection and Liver Diseases, The First Affiliated Hospital of Wenzhou Medical College, No. 2 Fuxue Lane, Wenzhou, Zhejiang, China b Department of Liver Diseases, Qingdao Municipal Hospital, Qingdao, Shandong Province, China c Department of Liver Diseases, Tianjin Infectious Disease Hospital, Tianjin, China d School of the First Clinical Medical Sciences, Wenzhou Medical College, Wenzhou, China e Center of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China f Cancer Center, Nanjing Drum Tower Hospital, Nanjing Medical University, Nanjing, China |
| Abstract: | Non-alcoholic fatty liver disease (NAFLD) is and will continue to be a major liver health issue worldwide in the coming decades. There are no leading drug candidates at this point, although there are several promising concepts in drug development. Recent studies have proposed a possible role of intestinal bacterial overgrowth in the development of non-alcoholic steatohepatitis, thus indicated probiotics maybe a potential specific liver drug for NAFLD in the future. |
| Keywords: | Probiotics Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis Therapy |
| 本文献已被 ScienceDirect 等数据库收录！ | |